A stromal-free, serum-free system to expand ex vivo hematopoietic stem cells from mobilized peripheral blood of patients with hematologic malignancies and healthy donors

Cytotherapy

Volumn 15, Issue 9, 2013, Pages 1126-1135

  Yao, Chao Ling ^a   Hsu, Shu Ching ^b   Hwang, Shiaw Min ^c   Lee, Wei Chi ^a   Chiou, Tzeon Jye ^d,e  

^a YUAN ZE UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c FOOD INDUSTRY RESEARCH AND DEVELOPMENT INSTITUTE   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Ex vivo expansion; Hematopoietic stem cell; Mobilized peripheral blood; Serum free; Stem cell transplantation; Stromal free

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; MEMBRANE ANTIGEN; MESSENGER RNA; TELOMERASE REVERSE TRANSCRIPTASE;

ABCG2 GENE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CELL CULTURE; CELL DIFFERENTIATION; CELL EXPANSION; CELL PROLIFERATION; CLINICAL ARTICLE; COLONY FORMING CELL; CONTROLLED STUDY; CULTURE MEDIUM; EX VIVO STUDY; GENE; GENE EXPRESSION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOXB4 GENE; HTERT GENE; HUMAN; HUMAN CELL; IMMOBILIZED CELL; IN VIVO STUDY; LEUKOCYTE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; NONHUMAN; PRIORITY JOURNAL;

MUS;

EX VIVO EXPANSION; HEMATOPOIETIC STEM CELL; MOBILIZED PERIPHERAL BLOOD; SERUM-FREE; STEM CELL TRANSPLANTATION; STROMAL-FREE;

ANIMALS; ANTIGENS, CD; ATP-BINDING CASSETTE TRANSPORTERS; CELL CULTURE TECHNIQUES; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASM PROTEINS; RNA, MESSENGER; STEM CELLS; STROMAL CELLS; TISSUE DONORS;

EID: 84881089443     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2013.04.002     Document Type: Article

References (48)

1. McAdams T.A., Miller W.M., Papoutsakis E.T. Hematopoietic cell culture therapies (part I): cell culture considerations. Trends Biotechnol 1996, 14:341-349.
2. Sutherland H.J., Lansdrop P.M., Henkelman D.H., Eaves S.C., Eaves C.J. Functional characterization of individual human hematopoietic stem cells at limiting dilution on supportive marrow stromal layers. Proc Natl Acad Sci U S A 1990, 87:3584-3588.
3. Prosper F., Vanoverbeke K., Stroncek D., Verfaillie C.M. Primitive long-term culture initialing cells (LTC-ICs) in granulocyte colony-stimulating factor mobilized peripheral blood progenitor cells have similar potential for ex vivo expansion as primitive LTC-ICs in steady state bone marrow. Blood 1997, 89:3991-3997.
4. Zimmermann S., Glaser S., Ketteler R., Waller C.F., Klingmüller U., Martens U.M. Effects of telomerase modulation in human hematopoietic progenitor cells. Stem Cells 2004, 22:741-749.
5. Larochelle A., Vormoor J., Hanenberg H., Wang J.C., Bhatia M., Lapidot T., et al. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implication for gene therapy. Nat Med 1996, 2:1329-1337.
6. Weissman I.L., Shizuru J.A. The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases. Blood 2008, 112:3543-3553.
7. Hill G.R., Inder A., Patton W.N., Hart D.N. High dose therapy and autologous bone marrow versus blood cell rescue. South Island bone marrow transplant unit. NEngl J Med 1996, 109:45-48.
8. To L.B., Roberts M.M., Haylock D.N., Dyson P.G., Branford A.L., Thorp D., et al. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant 1992, 9:277-284.
9. Reik R.A., Noto T.A., Fernandez H.F. Safety of large-volume leukapheresis for collection of peripheral blood progenitor cells. JClin Apher 1997, 12:10-13.
10. Majolino I., Cavallaro A.M., Scimè R. Peripheral blood stem cells for allogeneic transplantation. Bone Marrow Transplant 1996, 18(Suppl. 2):171-174.
11. Copelan E.A. Hematopoietic stem-cell transplantation. NEngl J Med 2006, 354:1813-1826.
12. Sanders J.E., Im H.J., Hoffmeister P.A., Gooley T.A., Woolfrey A.E., Carpenter P.A., et al. Allogeneic hematopoietic cell transplantation for infants with acute lymphoblastic leukemia. Blood 2005, 105:3749-3756.
13. Haas R., Möhle R., Frühauf S., Goldschmidt H., Witt B., Flentje M., et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cellsin malignant lymphoma. Blood 1994, 83:3787-3794.
14. Tyndall A., Daikeler T. Autologous hematopoietic stem cell transplantation for autoimmune diseases. Acta Haematol 2005, 114:239-247.
15. McAdams T.A., Winter J.N., Miller W.M., Papoutsakis E.T. Hematopoietic cell culture therapies (part II): clinical aspects and applications. Trends Biotechnol 1996, 14:388-396.
16. + cells as the best predictor of peripheral hematopoietic stem cell yield. JHematother 1999, 8:255-262.
17. + cells in autologous stem cell transplantation for breast cancer. Blood 1996, 87:1687-1691.
18. + cell doses for autologous hematopoietic stem cell transplantation?. Bone Marrow Transplant 2003, 31:861-864.
19. Audet J., Zandstra P.W., Eaves C.J., Piret J.M. Advances in hematopoietic stem cell culture. Curr Opin Biotechnol 1998, 9:146-151.
20. + hematopoietic stem cells. Exp Hematol 2000, 28:1297-1305.
21. de Lima M., Shpall E. Strategies for widening the use of cord blood in hematopoietic stem cell transplantation. Haematologica 2006, 91:584-587.
22. Shih C.C., Hu M.C., Hu J., Weng Y., Yazaki P.J., Medeiros J., et al. Asecreted and LIF-mediated stromal cell-derived activity that promotes ex vivo expansion of human hematopoietic stem cells. Blood 2000, 95:1957-1966.
23. Madkaikar M., Ghosh K., Gupta M., Swaminathan S., Mohanty D. Ex vivo expansion of umbilical cord blood stem cells using different combinations of cytokines and stromal cells. Acta Haematol 2007, 118:153-159.
24. Moore K.A., Lemischka I.R. Stem cells and their niches. Science 2006, 311:1880-1885.
25. Freund D., Bauer N., Boxberger S., Feldmann S., Streller U., Ehninger G., et al. Polarization of human hematopoietic progenitors during contact with multipotent mesenchymal stromal cells: effects on proliferation and clonogenicity. Stem Cells Dev 2006, 15:815-829.
26. Wagner W., Wein F., Roderburg C., Saffrich R., Faber A., Krause U., et al. Adhesion of hematopoietic progenitor cells to human mesenchymal stem cells as a model for cell-cell interaction. Exp Hematol 2007, 35:314-325.
27. Wagner W., Wein F., Roderburg C., Saffrich R., Faber A., Krause U., et al. Rapid ex vivo expansion of human umbilical cord hematopoietic progenitors using a novel culture system. Exp Hematol 1999, 27:904-915.
28. Freshney R.I. The culture environment: substrate, gas phase, medium, and temperature. Culture of animal cells 1994, 71-103. Wiley-Liss Inc, New York. R.I. Freshney (Ed.).
29. Yao C.L., Liu C.C., Chu I.M., Hsieh T.B., Hwang S.M. Factorial designs combined with the steepest ascent method to optimize serum-free media for ex vivo expansion of human hematopoietic progenitor cells. Enzyme Microb Technol 2003, 33:343-352.
30. + cells. Stem Cells Dev 2006, 15:70-78.
31. Bronchud M.H. Recombinant human granulocyte colony-stimulating factor in the management of cancer patients: five years on. Oncology 1994, 51:189-197.
32. Stern A.C., Jones T.C. The side-effect profile of GM-CSF. Infection 1992, 20(Suppl. 2):S124-S127.
33. Gaia S., Smedile A., Omedè P., Olivero A., Sanavio F., Balzola F., et al. Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease. Hepatology 2006, 45:13-19.
34. Ivanovic Z., Boiron J.M. Ex vivo expansion of hematopoietic stem cells: concept and clinical benefit. Transfus Clin Biol 2009, 16:489-500.
35. + cell-enrichment of cord blood determines hematopoietic stem/progenitor cell yield upon ex vivo expansion. JCell Biochem 2011, 112:1822-1831.
36. Benveniste P., Frelin C., Janmohamed S., Barbara M., Herrington R., Hyam D., et al. Intermediate-term hematopoietic stem cells with extended but time-limited reconstitution potential. Cell Stem Cell 2010, 6:48-58.
37. Bhatia M., Bonnet D., Kapp U., Wang J.C., Murdoch B., Dick J.E. Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. JExp Med 1997, 186:619-624.
38. Sandstrom C.E., Bender J.G., Miller W.M., Papoutsakis E.T. Development of novel perfusion chamber to retain nonadherent cells and its use for comparison of human "mobilized" peripheral blood mononuclear cell cultures with and without irradiated bone marrow stroma. Biotechnol Bioeng 1996, 50:493-504.
39. Collins P.C., Miller W.M., Papoutsakis E.T. Stirred culture of peripheral and cord blood hematopoietic cells offers advantages over traditional static systems for clinically relevant applications. Biotechnol Bioeng 1998, 59:534-543.
40. + cells mobilized in peripheral blood. Transfusion 2011, 51:313-318.
41. + cells without significant cell senescence using a stromal cell coculture system with single cytokine support. Stem Cells Dev 2009, 18:229-234.
42. + selected cells from cancer patientsmobilized with combination chemotherapy and granulocyte colony-stimulating factor. Vox Sang 2008, 94:342-350.
43. Auvray C., Delahaye A., Pflumio F., Haddad R., Amsellem S., Miri-Nezhad A., et al. HOXC4 homeoprotein efficiently expands human hematopoietic stem cells and triggers similar molecular alterations as HOXB4. Haematologica 2012, 97:168-178.
44. Ohno Y., Yasunaga S., Ohtsubo M., Mori S., Tsumura M., Okada S., et al. Hoxb4 transduction down-regulates Geminin protein, providing hematopoietic stem and progenitor cells with proliferation potential. Proc Natl Acad Sci U S A 2010, 107:21529-21534.
45. Ahmed F., Arseni N., Glimm H., Hiddemann W., Buske C., Feuring-Buske M. Constitutive expression of the ATP-binding cassette transporter ABCG2 enhances the growth potential of early human hematopoietic progenitors. Stem Cells 2008, 26:810-818.
46. Kim M., Turnquist H., Jackson J., Sgagias M., Yan Y., Gong M., et al. The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells. Clin Cancer Res 2002, 8:22-28.
47. Van Ziffle J.A., Baerlocher G.M., Lansdorp P.M. Telomere length in subpopulations of human hematopoietic cells. Stem Cells 2003, 21:654-660.
48. Zimmermann S., Martens U.M. Telomere dynamics in hematopoietic stem cells. Curr Mol Med 2005, 5:179-185.